odmj
OncoDaily Medical Journal
ODMJ
3067-6444
OncoDaily Medical Journal
US
4320
10.69690/ODMJ-018-0425-4320
Commentaries
Colorectal Cancer in Latin America: Quick Comment
Michaus
Veronica Salais
Gastrointestinal Oncology Department and Traslational Medicine Laboratory, Instituto Nacional de Cancerologia, Mexico
Ruiz-Garcia
Erika
Gastrointestinal Oncology Department and Traslational Medicine Laboratory, Instituto Nacional de Cancerologia, Mexico
betzabe100@yahoo.com.mx
21
07
2025
ODMJ-018-0425-4320
Copyright (c) 2025 OncoDaily Medical Journal
2025
OncoDaily Medical Journal
colorectal cancer
Commentaries
LATAM
Latin America
production-ready-file-url
[
Bray F, Laversanne M, Sung H, et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2024 May-Jun;74(3):229-63.
]
[
Gobierno de México. 131. Necesario modificar estilos de vida para evitar desarrollo de cáncer colorrectal: INCan [Internet]. Secretaría de Salud; [cited 2025 Jul 9]. Available from: https://www.gob.mx/salud/prensa/131-necesario-modificar-estilos-de-vida-para-evitar-desarrollo-de-cancer-colorrectal-incan?idiom=es
]
[
Piñeros M, Laversanne M, Barrios E, et al. An updated profile of the cancer burden, patterns, and trends in Latin America and the Caribbean. Lancet Reg Health Am. 2022 Sep;13:100294.
]
[
Araghi M, Soerjomataram I, Jenkins M, et al. Global trends in colorectal cancer mortality: projections to the year 2035. Int J Cancer. 2019 Jun 15;144(12):2992-3000.
]
[
Muzi CD, Banegas MP, Guimarães RM, et al. Colorectal cancer disparities in Latin America: mortality trends 1990–2019 and a paradox association with human development. PLoS One. 2023 Aug 25;18(8):e0289675.
]
[
SEER Cancer Statistics. Colorectal cancer [Internet]. National Cancer Institute; [cited 2025 Jul 9]. Available from: https://seer.cancer.gov/statfacts/html/colorect.html
]
[
Reynoso-Noverón N, Meneses-García A, Erazo-Valle A, et al. Challenges in the development and implementation of the National Comprehensive Cancer Control Program in Mexico. Salud Publica Mex. 2016 Apr;58(2):325-33.
]
[
Modest DP, Pant S, Sartore-Bianchi A, et al. Treatment sequencing in metastatic colorectal cancer. Eur J Cancer. 2019 Mar;109:70-83.
]
[
Ji J, Wang C, Fakih M, et al. Targeting KRASG12C-mutated advanced colorectal cancer: research and clinical developments. Onco Targets Ther. 2022 Jul 7;15:747-56.
]
[
Tabernero J, Ros J, Élez E, et al. The evolving treatment landscape in BRAF-V600E-mutated metastatic colorectal cancer. Am Soc Clin Oncol Educ Book. 2022 Apr;42:1-10.
]
[
Seo AN, Kwak Y, Kim DW, et al. HER2 status in colorectal cancer: its clinical significance and the relationship between HER2 gene amplification and expression. PLoS One. 2014 May 30;9(5):e98528.
]
[
Koopman M, Kortman GA, Mekenkamp L, et al. Deficient mismatch repair system in patients with sporadic advanced colorectal cancer. Br J Cancer. 2009 Jan 27;100(2):266-73.
]
[
Di Mauro A, Santorsola M, Savarese G, et al. High tumor mutational burden assessed through next-generation sequencing predicts favorable survival in microsatellite stable metastatic colon cancer patients. J Transl Med. 2024 Dec 5;22(1):1107.
]
[
López RI, Castro JL, Cedeño H, et al. Consensus on management of metastatic colorectal cancer in Central America and the Caribbean: San José, Costa Rica, August 2016. ESMO Open. 2018 Mar 15;3(3):e000315.
]
[
Quesada-Soto P, Landaverde D, Ramos-Esquivel A, et al. Liver metastasectomy and systemic therapy improve overall survival compared with surgery alone after curative liver resection of colorectal metastases in a developing country (Costa Rica). J Glob Oncol. 2016 May 4;3(1):31-6.
]
[
Nunes Filho PRS, et al. Latin America and cancer clinical trials: underrepresented region with significant growth potential. J Clin Oncol. 2024;42:e23038.
]
[
Jácome AA, Mathias-Machado MC, Gil M, et al. Later lines of systemic therapy in patients with metastatic colorectal cancer: real-world data from a setting with barriers to access cancer therapies. J Gastrointest Oncol. 2024 Dec 31;15(6):2543-51.
]
[
Catani G, Kim S, Waisberg F, et al. Patients with colorectal cancer and BRAF V600E mutation in Argentina: a real-world study – the EMOGI-CRC01 study. Cancers (Basel). 2025;17(6):1007.
]
[
O’Connor J, Torrecillas L, Alvarado F, et al. Biomarkers and treatment characteristics in metastatic colorectal cancer RASwt patients in Latin America. Gac Mex Oncol. 2023;22(1):24-33.
]
[
White C, Scott RJ, Paul C, et al. Ethnic diversity of DPD activity and the DPYD gene: review of the literature. Pharmgenomics Pers Med. 2021 Dec 9;14:1603-17.
]
[
Montalvan-Sanchez EE, Norwood DA, Dougherty M, et al. Colorectal cancer screening programs in Latin America: a systematic review and meta-analysis. JAMA Netw Open. 2024 Feb 5;7(2):e2354256.
]
[
Unger-Saldaña K, Saldaña-Tellez M, Potter MB, et al. Barriers and facilitators for colorectal cancer screening in a low-income urban community in Mexico City. Implement Sci Commun. 2020 Jul 10;1:64.
]
[
Ferlay J, Ervik M, Lam F, et al. Global Cancer Observatory: cancer today [Internet]. Lyon, France: International Agency for Research on Cancer; 2024; [cited 2025 Jul 9]. Available from: https://gco.iarc.who.int/today
]
[
Reich M, Buki LP, et al. Colorectal cancer screening in Uruguay: current assessment and roadmap for the future. Psicol Reflex Crit. 2021 Jun 29;34(1):20.
]
[
Colón-López V, Valencia-Torres IM, Ríos EI, et al. Knowledge, attitudes, and beliefs about colorectal cancer screening in Puerto Rico. J Cancer Educ. 2023 Apr;38(2):552-61.
]
[
Fleitas-Kanonnikoff T, Martinez-Ciarpaglini C, Ayala J, et al. Molecular profile in Paraguayan colorectal cancer patients, towards a precision medicine strategy. Cancer Med. 2019 Jun;8(6):3120-30.
]
[
Lima Pérez M, Galán Álvarez YH, Soriano García JL, et al. Incidence and mortality of gastrointestinal cancer in Cuba, 2015–2017. Rev Cubana Oncol. 2021 May-Aug;19(2):e142.
]
[
Mondschein S, Subiabre F, Yankovic N, et al. Colorectal cancer trends in Chile: a Latin-American country with marked socioeconomic inequities. PLoS One. 2022 Nov 10;17(11):e0271929.
]
[
Campo-Sánchez SM, Camargo-Trillos J, Calle-Ramírez JA, et al. Colorectal cancer survival at an oncologic center in Colombia: a historic cohort study. Rev Gastroenterol Mex (Engl Ed). 2019 Apr-Jun;84(2):174-84.
]
[
Campo-Sánchez SM, Camargo-Trillos J, Calle-Ramírez JA, et al. Colorectal cancer survival at an oncologic center in Colombia: a historic cohort study. Rev Gastroenterol Mex (Engl Ed). 2019 Apr-Jun;84(2):174-84.
]
[
Dantas AAG, de Oliveira NPD, Costa GAB, et al. Multilevel analysis of social determinants of advanced stage colorectal cancer diagnosis. Sci Rep. 2024 Apr 26;14(1):9667.
]
[
Ramos-Esquivel A, Garita-Rojas E, Masís-Marroquín A, et al. Determinantes de supervivencia en una cohorte de pacientes costarricenses con cáncer colorrectal. Acta Méd Costarric. 2022;64(2):16-23.
]
[
Caramutti-Pasco BA, Oyola-García AE, Quispe-Ilanzo MP, et al. Caracterización clínica y colonoscópica del adenocarcinoma colorrectal en un hospital peruano de la seguridad social. Rev Cuerpo Med HNAAA. 2017;10(4).
]
[
Cueva P, Tarupi W, Caballero H, et al. Cancer incidence and mortality in Quito: information to monitor cancer control policies. Colomb Med (Cali). 2022 Feb 9;53(1):e2024929.
]
[
Lozano-Esparza S, Sánchez-Blas HR, Huitzil-Meléndez FD, et al. Colorectal cancer survival in Mexico: leveraging a national health insurance database. Cancer Epidemiol. 2025 Feb;94:102698.
]